These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16357803)

  • 1. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control.
    Cakatay U
    Diabetes Metab; 2005 Dec; 31(6):551-7. PubMed ID: 16357803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
    Kostolanská J; Jakus V; Barák L
    J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antioxidant status of female diabetic patients in Nnamdi Azikiwe University Teaching Hospital, Anambra State, Nigeria.
    Okuonghae EO; Onyenekwe CC; Ahaneku JE; Ukibe NR; Nwani PO; Asomugha AL; Osakue NO; Aidomeh F; Awalu CC
    Br J Biomed Sci; 2015; 72(4):164-7. PubMed ID: 26738397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative protein damage in early stage Type 1 diabetic patients.
    Telci A; Cakatay U; Salman S; Satman I; Sivas A
    Diabetes Res Clin Pract; 2000 Dec; 50(3):213-23. PubMed ID: 11106836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
    Odetti P; Traverso N; Cosso L; Noberasco G; Pronzato MA; Marinari UM
    Diabetologia; 1996 Dec; 39(12):1440-7. PubMed ID: 8960824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
    Turk Z; Mesić R; Benko B
    Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress.
    Cominacini L; Fratta Pasini A; Garbin U; Campagnola M; Davoli A; Rigoni A; Zenti MG; Pastorino AM; Lo Cascio V
    Diabetologia; 1997 May; 40(5):584-9. PubMed ID: 9165228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
    Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
    Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus.
    Jakuš V; Sándorová E; Kalninová J; Krahulec B
    Physiol Res; 2014; 63(3):297-309. PubMed ID: 24564602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein carbonyl content in erythrocyte membranes in type 2 diabetic patients.
    Konukoğlu D; Kemerli GD; Sabuncu T; Hatemi HH
    Horm Metab Res; 2002 Jul; 34(7):367-70. PubMed ID: 12189583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats.
    Kayali R; Telci A; Cakatay U; Karaca C; Akcay T; Sivas A; Altug T
    Eur J Med Res; 2003 Jul; 8(7):307-12. PubMed ID: 12911868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control and associated factors among patients with diabetes at public health clinics in Johor, Malaysia.
    Mahmood MI; Daud F; Ismail A
    Public Health; 2016 Jun; 135():56-65. PubMed ID: 26976488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C; Winocour PD
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):513-9. PubMed ID: 1457612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus.
    Ain Q; Latif A; Jaffar SR; Ijaz A
    J Pak Med Assoc; 2017 Sep; 67(9):1353-1356. PubMed ID: 28924273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats.
    Aydın AF; Bingül İ; Küçükgergin C; Doğan-Ekici I; Doğru Abbasoğlu S; Uysal M
    Int J Exp Pathol; 2017 Oct; 98(5):278-288. PubMed ID: 29205589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ojo O; Ojo OO; Adebowale F; Wang XH
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.